Jeffrey H. Maki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jeffrey H. Maki has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Gregory J. Wilson
Philips Healthcare, Cleveland, Ohio, USA
3 shared publicationsSilke Potthast
Department of Radiology, University of Washington, Seattle, Washington, USA
2 shared publications- Bruce E. Lehnert
Department of Radiology, University of Washington School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA
1 shared publication David J. Glickerman
Puget Sound VA Health Care System, Department of Radiology, Seattle, Washington
1 shared publication- Dhakshinamoorthy Ganeshan
The University of Texas MD Anderson Cancer Center, Houston, USA
1 shared publication G R Oliveira
1 shared publication
Latest Publications
- 9 May 2014
- Published by Springer Nature in Abdominal Radiology
- Vol. 39 (6) , 1330-1349
Multimodality imaging of diseases of the duodenum
The duodenum is a unique segment of intestine, occupying both intra and extra-peritoneal locations. There is a wide spectrum of abnormalities of the duodenum that range from congenital anomalies to traumatic, inflammatory, and neoplastic entities. The duodenum may be overlooked on cross-sectional imaging due to its location and small size. Duodenal pathologies may, therefore, be missed or wrongly diagnosed. Knowledge about duodenal pathologies and optimal imaging techniques can increase diagnostic yield and permit optimal patient management. Conventionally, the duodenum was evaluated with upper GI studies on fluoroscopy; however, endoluminal evaluation is better performed with endoscopy. Additionally, a broad array of cross-sectional imaging modalities permits comprehensive assessment of the duodenum and surrounding viscera. While endoscopic sonography is increasingly used to locally stage duodenal malignancies, MDCT remains the primary modality widely used in the detection and characterization of duodenal abnormalities. MRI is used as a "problem solving" modality in select conditions. We present a comprehensive review of duodenal abnormalities with an emphasis on accurate diagnosis and management.
- 9 May 2014
- Published by Springer Nature in Abdominal Radiology
- Vol. 39 (6) , 1330-1349
Multimodality imaging of diseases of the duodenum
The duodenum is a unique segment of intestine, occupying both intra and extra-peritoneal locations. There is a wide spectrum of abnormalities of the duodenum that range from congenital anomalies to traumatic, inflammatory, and neoplastic entities. The duodenum may be overlooked on cross-sectional imaging due to its location and small size. Duodenal pathologies may, therefore, be missed or wrongly diagnosed. Knowledge about duodenal pathologies and optimal imaging techniques can increase diagnostic yield and permit optimal patient management. Conventionally, the duodenum was evaluated with upper GI studies on fluoroscopy; however, endoluminal evaluation is better performed with endoscopy. Additionally, a broad array of cross-sectional imaging modalities permits comprehensive assessment of the duodenum and surrounding viscera. While endoscopic sonography is increasingly used to locally stage duodenal malignancies, MDCT remains the primary modality widely used in the detection and characterization of duodenal abnormalities. MRI is used as a "problem solving" modality in select conditions. We present a comprehensive review of duodenal abnormalities with an emphasis on accurate diagnosis and management.
- 20 December 2009
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 31 (1) , 177-184
Measuring aortic diameter with different MR techniques: Comparison of three‐dimensional (3D) navigated steady‐state free‐precession (SSFP), 3D contrast‐enhanced magnetic resonance angiography (CE‐MRA), 2D T2 black blood, and 2D cine SSFP
Purpose: To compare nongated three‐dimensional (3D) contrast‐enhanced magnetic resonance angiography (CE‐MRA) with 3D‐navigated cardiac‐gated steady‐state free‐precession bright blood (3D‐nav SSFP) and noncontrast 2D techniques for ascending aorta dimension measurements.Materials and Methods: Twenty‐five clinical exams were reviewed to evaluate the ascending aorta at 1.5T using: breathhold cine bright blood (SSFP), cardiac‐triggered T2 black blood (T2 BB), axial 3D‐nav SSFP, and nongated 3D CE‐MRA. Three radiologists independently measured aortic size at three specified locations for each sequence. Means, SDs, interobserver correlation, and vessel edge sharpness were statistically evaluated.Results: Measurements were greatest for 3D‐nav SSFP and 3D CE‐MRA and smallest for T2 BB. There was no significant difference between 3D‐nav SSFP and 3D CE‐MRA (P = 0.43–0.86), but significance was observed comparing T2 BB to all sequences. Interobserver agreement was uniformly >0.9, with T2 BB best, followed closely by 3D‐nav SSFP and 2D cine SSFP, and 3D CE‐MRA being the worst. Edge sharpness was significantly poorer for 3D CE‐MRA compared to the other sequences (P < 0.001).Conclusion: If diameter measurements are the main clinical concern, 3D‐nav SSFP appears to be the best choice, as it has a sharp edge profile, is easy to acquire and postprocess, and shows very good interobserver correlation. J. Magn. Reson. Imaging 2010;31:177–184.
- 20 December 2009
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 31 (1) , 177-184
Measuring aortic diameter with different MR techniques: Comparison of three‐dimensional (3D) navigated steady‐state free‐precession (SSFP), 3D contrast‐enhanced magnetic resonance angiography (CE‐MRA), 2D T2 black blood, and 2D cine SSFP
Purpose: To compare nongated three‐dimensional (3D) contrast‐enhanced magnetic resonance angiography (CE‐MRA) with 3D‐navigated cardiac‐gated steady‐state free‐precession bright blood (3D‐nav SSFP) and noncontrast 2D techniques for ascending aorta dimension measurements.Materials and Methods: Twenty‐five clinical exams were reviewed to evaluate the ascending aorta at 1.5T using: breathhold cine bright blood (SSFP), cardiac‐triggered T2 black blood (T2 BB), axial 3D‐nav SSFP, and nongated 3D CE‐MRA. Three radiologists independently measured aortic size at three specified locations for each sequence. Means, SDs, interobserver correlation, and vessel edge sharpness were statistically evaluated.Results: Measurements were greatest for 3D‐nav SSFP and 3D CE‐MRA and smallest for T2 BB. There was no significant difference between 3D‐nav SSFP and 3D CE‐MRA (P = 0.43–0.86), but significance was observed comparing T2 BB to all sequences. Interobserver agreement was uniformly >0.9, with T2 BB best, followed closely by 3D‐nav SSFP and 2D cine SSFP, and 3D CE‐MRA being the worst. Edge sharpness was significantly poorer for 3D CE‐MRA compared to the other sequences (P < 0.001).Conclusion: If diameter measurements are the main clinical concern, 3D‐nav SSFP appears to be the best choice, as it has a sharp edge profile, is easy to acquire and postprocess, and shows very good interobserver correlation. J. Magn. Reson. Imaging 2010;31:177–184.
- 23 October 2009
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 30 (5) , 1085-1092
Highly accelerated first‐pass contrast‐enhanced magnetic resonance angiography of the peripheral vasculature: Comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents
Purpose: To investigate the blood pool agent gadofosveset trisodium for first‐pass, dynamic peripheral contrast‐enhanced magnetic resonance angiography (pMRA), and compare the results with a conventional gadolinium contrast agent.Materials and Methods: A total of 16 patients were imaged at 1.5T using a prototype peripheral vascular coil with high SENSE acceleration. Five received gadopentetate dimeglumine (≈0.25 mmol/kg), and 11 received gadofosveset trisodium (five standard‐dose 0.03 mmol/kg, six high‐dose 0.05 mmol/kg). Quantitative contrast‐enhancement and qualitative image quality evaluation was compared between agents and doses.Results: High‐quality diagnostic images were uniformly obtained. The contrast ratio did not significantly differ between gadopentetate dimeglumine and high‐dose gadofosveset trisodium, both of which were greater than standard‐dose gadofosveset trisodium. High‐dose gadofosveset trisodium was equivalent to gadopentetate dimeglumine in image quality and subjective vessel‐to‐background ratio, but significantly better for depicting small muscular arteries. Standard‐dose gadofosveset trisodium showed equivalent image quality and small artery depiction with a slight but significant decrease in vessel‐to‐background ratio as compared to gadopentatate dimeglumine. Both gadofosveset trisodium doses trended toward more venous enhancement, but this was not a diagnostic problem.Conclusion: First‐pass peripheral CE‐MRA using gadofosveset trisodium is feasible, yielding image quality comparable to double to triple‐dose gadopentetate dimeglumine. Increasing the gadofosveset trisodium dose to 0.05 mmol/kg yields further improvements. J. Magn. Reson. Imaging 2009;30:1085–1092.
- 23 October 2009
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 30 (5) , 1085-1092
Highly accelerated first‐pass contrast‐enhanced magnetic resonance angiography of the peripheral vasculature: Comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents
Purpose: To investigate the blood pool agent gadofosveset trisodium for first‐pass, dynamic peripheral contrast‐enhanced magnetic resonance angiography (pMRA), and compare the results with a conventional gadolinium contrast agent.Materials and Methods: A total of 16 patients were imaged at 1.5T using a prototype peripheral vascular coil with high SENSE acceleration. Five received gadopentetate dimeglumine (≈0.25 mmol/kg), and 11 received gadofosveset trisodium (five standard‐dose 0.03 mmol/kg, six high‐dose 0.05 mmol/kg). Quantitative contrast‐enhancement and qualitative image quality evaluation was compared between agents and doses.Results: High‐quality diagnostic images were uniformly obtained. The contrast ratio did not significantly differ between gadopentetate dimeglumine and high‐dose gadofosveset trisodium, both of which were greater than standard‐dose gadofosveset trisodium. High‐dose gadofosveset trisodium was equivalent to gadopentetate dimeglumine in image quality and subjective vessel‐to‐background ratio, but significantly better for depicting small muscular arteries. Standard‐dose gadofosveset trisodium showed equivalent image quality and small artery depiction with a slight but significant decrease in vessel‐to‐background ratio as compared to gadopentatate dimeglumine. Both gadofosveset trisodium doses trended toward more venous enhancement, but this was not a diagnostic problem.Conclusion: First‐pass peripheral CE‐MRA using gadofosveset trisodium is feasible, yielding image quality comparable to double to triple‐dose gadopentetate dimeglumine. Increasing the gadofosveset trisodium dose to 0.05 mmol/kg yields further improvements. J. Magn. Reson. Imaging 2009;30:1085–1092.
- Open Access
- 22 April 2009
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 29 (5) , 1106-1115
Peripheral moving-table contrast-enhanced magnetic resonance angiography (CE-MRA) using a prototype 18-channel peripheral vascular coil and scanning parameters optimized to the patient's individual hemodynamics
- 22 April 2009
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 29 (5) , 1106-1115
Open AccessPeripheral moving-table contrast-enhanced magnetic resonance angiography (CE-MRA) using a prototype 18-channel peripheral vascular coil and scanning parameters optimized to the patient's individual hemodynamics
- 25 September 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 26 (4) , 966-973
Steady‐state free precession MRA of the renal arteries: Breath‐hold and navigator‐gated techniques vs. CE‐MRA
Purpose To explore the use of breath‐hold and navigator‐gated noncontrast Steady State Free Precession (SSFP) MR angiography (MRA) protocols for the evaluation of renal artery stenosis (RAS). Materials and Methods Twenty patients referred to rule out RAS were imaged using two breath‐hold and one navigator‐gated SSFP MRA sequences. All patients underwent contrast‐enhanced MRA (CE‐MRA). Two radiologists evaluated all sequences both qualitatively (blur, artifacts, reader confidence) and quantitatively (maximum stenosis). Using CE‐MRA as truth, a receiver operating characteristics (ROC) curve was generated and a statistical analysis of navigator‐gated SSFP (Nav SSFP) was performed. Results Seven patients had >50% renal artery stenosis by CE‐MRA. Nav SSFP performed significantly better than either breath‐hold SSFP technique in terms of blur, artifacts, and reader confidence. Using a 50% threshold for stenosis, sensitivity for detecting RAS was 100%, with a specificity of 85% and a negative predictive value of 100%. The average mean stenosis difference between Nav SSFP and CE‐MRA was 9 ± 9%. Conclusion Nav SSFP outperformed breath‐hold SSFP in measures of image quality and reader confidence. Sensitivity and negative predictive value for detecting RAS with Nav SSFP was perfect, with an acceptable specificity of 85%. This suggests further study is warranted to evaluate Nav SSFP as a noncontrast screening technique for renal artery stenosis. J. Magn. Reson. Imaging 2007;26:966–973.
- 25 September 2007
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 26 (4) , 966-973
Steady‐state free precession MRA of the renal arteries: Breath‐hold and navigator‐gated techniques vs. CE‐MRA
Purpose To explore the use of breath‐hold and navigator‐gated noncontrast Steady State Free Precession (SSFP) MR angiography (MRA) protocols for the evaluation of renal artery stenosis (RAS). Materials and Methods Twenty patients referred to rule out RAS were imaged using two breath‐hold and one navigator‐gated SSFP MRA sequences. All patients underwent contrast‐enhanced MRA (CE‐MRA). Two radiologists evaluated all sequences both qualitatively (blur, artifacts, reader confidence) and quantitatively (maximum stenosis). Using CE‐MRA as truth, a receiver operating characteristics (ROC) curve was generated and a statistical analysis of navigator‐gated SSFP (Nav SSFP) was performed. Results Seven patients had >50% renal artery stenosis by CE‐MRA. Nav SSFP performed significantly better than either breath‐hold SSFP technique in terms of blur, artifacts, and reader confidence. Using a 50% threshold for stenosis, sensitivity for detecting RAS was 100%, with a specificity of 85% and a negative predictive value of 100%. The average mean stenosis difference between Nav SSFP and CE‐MRA was 9 ± 9%. Conclusion Nav SSFP outperformed breath‐hold SSFP in measures of image quality and reader confidence. Sensitivity and negative predictive value for detecting RAS with Nav SSFP was perfect, with an acceptable specificity of 85%. This suggests further study is warranted to evaluate Nav SSFP as a noncontrast screening technique for renal artery stenosis. J. Magn. Reson. Imaging 2007;26:966–973.